TERT and cancer: In particular, recurrent somatic mutations in the TERT promoter have been identified in various cancer types (42–45), and are associated with increased expression of TERT. Although the importance of TERT up-regulation in cancer has been well-established for nearly two decades (46), it is only in recent years that we've identified the regulatory mechanism driving TERT up-regulation in such cases.